Categories
rss rss-es rss-pt

Ferring US Issues Voluntary Nationwide Recall of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 mg/mL Due to Superpotency

Murilo Freitas - 04:00, 4 de agosto de 2020673
Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE® Nasal Spray 1.5 mg/mL listed in the table below to the consumer level. These products are being recalled due to superpotency or a

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ferring-us-issues-voluntary-nationwide-recall-ddavpr-nasal-spray-10-mcg01ml-desmopressin-acetate

 
Categories
rss rss-es rss-pt

CME America Updates Recall of BodyGuard Infusion Pump System Due to Risk of Over-, and Under-infusion

Murilo Freitas - 04:00, 4 de agosto de 2020547
CME America BodyGuard® Infusion System Administration Sets because the pumps may have a slower than expected delivery of medication (under-infusion), or faster than expected delivery of medication (over-infusion) or a delay in therapy.

http://www.fda.gov/medical-devices/medical-device-recalls/cme-america-updates-recall-bodyguard-infusion-pump-system-due-risk-over-and-under-infusion

 
PRAIS 2.0